US 12121522
Methods of treating cancer with an mTOR inhibitor
granted A61KA61K31/436A61K31/4433
Quick answer
US patent 12121522 (Methods of treating cancer with an mTOR inhibitor) held by Revolution Medicines, Inc. expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Revolution Medicines, Inc.
- Grant date
- Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/436, A61K31/4433, A61K31/519, A61K47/545